Universities and translational research organisations generate many of the most promising biologics concepts – but a result that works in a research lab is not yet a process that can be developed, transferred or funded. Z2 helps research teams view their science through an industrial development lens, identifying what needs to change as a concept progresses towards a reproducible, scalable and manufacturable process.
Success often requires more than solving an individual experiment: it needs the right development strategy, laboratory capability, experimental framework, technical knowledge and trained scientific teams. With a PhD and postdoctoral research at The University of Manchester, and experience of securing more than £3 million in research and innovation funding, Z2's founder understands both sides of the translation gap.
How Z2 helps
- Research processes made scalable
- Translational strategy from proof-of-concept towards industry-ready development
- CMC input for spin-outs and grant applications
- Experimental frameworks built on QbD, DoE and scale-down models
- Cell line, media and upstream process development expertise
- Laboratory set-up, workflows, SOPs and GMO/biosafety compliance
- Building and mentoring technical teams
- Industry-relevant training in DoE, QbD, upstream PD and AI/ML
Where rushed timelines break
Strong proof-of-concept data alongside a process that cannot scale, or capability stood up with no prior experience of what it takes – mismatches that are usually invisible to non-technical funders.
Where Z2 helps
An industrial view of the process early, experience of establishing CLD and process development laboratories from scratch, and a scientifically credible development and funding narrative.
